DonCRockeyMD

Gastroenterology • Charleston, SC

Hepatology & Liver Transplantation

Chairman, Department of Medicine

Join to view full profile

Dr. Rockey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rockey's full profile

Already have an account?

Office
171 Ashley Ave
Charleston, SC 29425
Phone+1 843-792-1414

Education & Training

University of California (San Francisco)Fellowship, Gastroenterology, 1988 - 1992
University of California (San Francisco)Residency, Internal Medicine, 1984 - 1988
Virginia Commonwealth University School of MedicineClass of 1984

Certifications & Licensure

CA State Medical License 1986 - Present
NC State Medical License 1997 - 2025
SC State Medical License 2013 - 2025
FL State Medical License 2019 - 2021
TX State Medical License 2006 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Elected Member American Association of Physicians, 2007
Fellow (AGAF) American Gastroenterological Association, 2006
Elected Member The American Society for Clinical Investigation, 2001
Fellow (FACP) American College of Physicians, 2000
Join now to see all

Clinical Trials

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer Start of enrollment: 2000 Aug 01
Terminated
Not Applicable
Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension Start of enrollment: 2008 Jul 01
Terminated
Phase 2
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy. Start of enrollment: 2011 Jan 01
Completed
Not Applicable
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding Start of enrollment: 2013 Mar 01
Withdrawn
Not Applicable
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis Start of enrollment: 2015 Jun 01
Completed
Phase 2
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Start of enrollment: 2018 Sep 19
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

19 citations
The beneficial effect of beta-blockers in patients with cirrhosis, portal hypertension and ascites
Ariel W. Aday, Marlyn J. Mayo, Alan C. Elliott, Don C. Rockey
The American Journal of the Medical Sciences. 2016-02-01
208 citations
Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
Yasuko Iwakiri, Vijay H. Shah, Don C. Rockey
Journal of Hepatology. 2014-10-01
4 citations
Hemoglobin Monitoring in Acute Gastrointestinal Bleeding: Are We Monitoring Blood Counts Too Frequently?
Isaac Jaben, Roula Sasso, Don C. Rockey
The American Journal of Medicine. 2021-05-01

Other

Screening for Esophageal Varices in Patients with Hepatocellular Carcinoma
Don Rockey, MD, Gastrointestinal Endoscopy
https://www.doximity.com/articles/188a42d2-9d42-4a30-ab3a-fefe223ad8ed
UpToDate, Wolters Kluwer Health - 2012-09-24

Authored Content

Screening for Esophageal Varices in Patients with Hepatocellular CarcinomaJuly 2018
Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study☆April 2018

Press Mentions

Research Shows Need for Guideline Adjustment When Treating Variceal BleedingOctober 7th, 2024
Deep-Learning Tool Helps Identify Patients with CirrhosisMarch 15th, 2023
Biomarkers over Biopsies: A Highly Accurate and Minimally Invasive Test for Liver FibrosisApril 22nd, 2022
Join now to see all

Grant Support

Nitric Oxide And The Cellular Pathogenesis Of Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Pathogenesis Of Hepatic Fibrosis And Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2010
Regulation Of Stellate Cell ContractilityNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
Regulation Of Stellate Cell ContractilityNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
NO And The Cellular Pathogenesis Of Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases2004
NO And The Cellular Pathogenesis Of Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
Pathogenesis Of Hepatic Fibrosis And Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2004
Nitric Oxide And The LiverNational Institute Of Diabetes And Digestive And Kidney Diseases2003
Prospective Comparison Of Colonic Imaging TestNational Cancer Institute2000–2001
Lipocyte Contractility And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997
Lipocyte Contractility And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1997
Pathogenesis Of Hepatic Fibrosis And Portal HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases1996
Contractility Of Hepatic LipocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1992